Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Sep;30(3):338-9.
doi: 10.4274/Tjh.2013.0079. Epub 2013 Sep 5.

Is there an optimal timing of autologous stem-cell transplantation for multiple myeloma in the era of novel agents?

Selami Koçak Toprak  1
Affiliations

Is there an optimal timing of autologous stem-cell transplantation for multiple myeloma in the era of novel agents?

Selami Koçak Toprak. Turk J Haematol. 2013 Sep.
No abstract available

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. Harousseau JL. How to select among available options for the treatment of multiple myeloma. Ann Oncol. 2012;23(Suppl 10):334–338. - PubMed
    1. Harousseau JL, Moreau P. Autologous hematopoietic stem-cell transplantation for multiple myeloma. N Engl J Med. 2009;360:2645–2654. - PubMed
    1. Cavo M, Tacchetti P, Patriarca F, Petrucci MT, Pantani L, Galli M, Raimondo F, Di, Crippa C, Zamagni E, Palumbo A, Offidani M, Corradini P, Narni F, Spadano A, Pescosta N, Deliliers GL, Ledda A, Cellini C, Caravita T, Tosi P. Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study. Lancet. 2010;376:2075–2085. - PubMed
    1. Palumbo A, Gay F, Falco P, Crippa C, Montefusco V, Patriarca F, Rossini F, Caltagirone S, Benevolo G, Pescosta N, Guglielmelli T, Bringhen S, Offidani M, Giuliani N, Petrucci MT, Musto P, Liberati AM, Rossi G, Corradini P, Boccadoro M. Bortezomib as induction before autologous transplantation, followed by lenalidomide as consolidation-maintenance in untreated multiple myeloma patients. J Clin Oncol. 2010;28:800–807. - PubMed
    1. Blanes M. Role of autologous bone marrow transplant in multiple myeloma. Curr Opin Oncol. 2012;24:733–741. - PubMed

LinkOut - more resources